We are pleased to announce a plan to build a new R&D and manufacturing site in Singapore. The new site will further expand the capacity and capabilities of WuXi AppTec’s integrated enabling platform, better serving global partners and advancing healthcare innovation.
When completed, the site will serve a critical role in our global network, helping meet growing demand from multinational customers and strengthening collaborations with a wide range of partners. We’re excited to establish our presence in Singapore and continue to contribute to the region’s dynamic life sciences ecosystem.
Read the full press release: https://bit.ly/3cmZhb2